Source: Eur Respir J 2002; 19: 320-325



Rating:

Share or cite this content

Citations should be made in the following way:
Alegre J., Jufresa J., Segura R., Ferrer A., Armadans L., Aleman C., Marti R., Ruiz E., Fernandez de Sevi... T.. Pleural-fluid myeloperoxidase in complicated and noncomplicated parapneumonic pleural effusions. Eur Respir J 2002; 19: 320-325

Member's Comments

No comment yet.

Related content which might interest you: Pleural fluid IL-6 levels in the identification of the complicated parapneumonic pleural effusion Source: Annual Congress 2008 - Pleural effusion Year: 2008 Interelukin-17A is elevated in parapneumonic pleural effusions and is associated with neutrophils and VEGF Source: Eur Respir J 2006; 28: Suppl. 50, 551s Year: 2006 Prognostic features of residual pleural thickening in parapneumonic pleural effusions Source: Eur Respir J 2003; 21: 952-955 Year: 2003 Role of C-reactive protein in discriminating complicated and uncomplicated parapneumonic effusion from malignant and tuberculous pleural effusion Source: Virtual Congress 2021 – Clinical problems associated with cough, pleura and respiratory health status Year: 2021 D-Dimer as a marker of fibrinolytic activity in complicated parapneumonic effusions and empyema Source: Eur Respir J 2002; 20: Suppl. 38, 419s Year: 2002 Update on the management of parapneumonic pleural effusions Source: Virtual Congress 2021 – Spanish/Portuguese programme 2021 Year: 2021 Pleural fluid C-reactive protein concentration in discriminating uncomplicated from complicated parapneumonic pleural effusion Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections Year: 2012 Procalcitonin in pleural fluid: A new tool for the diagnosis of empyema and parapneumonic pleural effusions? Source: Annual Congress 2011 - New aspects in prevention and treatment of community-acquired pneumonia and lower respiratory tract infections Year: 2011 Parapneumonic effusion and empyema Source: Respipedia Article Year: 2017 Treatment of parapneumonic pleural effusion and empyema: conservative view Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=199 Year: 2004 Efficacy of intrapleural streptokinase use in complicated parapneumonic pleural effusions and empyema Source: Annual Congress 2008 - Pleural effusion Year: 2008 Prognostic features of residual pleural thickening after parapneumonic pleural effusion Source: Eur Respir J 2002; 20: Suppl. 38, 605s Year: 2002 Incidence and aetiology of eosinophilic pleural effusion Source: Eur Respir J 2009; 34: 1111-1117 Year: 2009 Predictors of outcome in parapneumonic pleural effusions in children Source: Eur Respir J 2001; 18: Suppl. 33, 171s Year: 2001 Pentraxin-3: A novel biomarker for the differentiation of parapneumonic effusion and malignant pleural effusion Source: Annual Congress 2012 - Novelties in clinical management of thoracic diseases: from diaphragm to pleura Year: 2012 Transudative malignant pleural effusions Source: International Congress 2019 – Novel approaches to pleural effusion: should I change my practice? Year: 2019 Value of pleural fluid and serum NT-ProBNP levels in differentiation of transudative and exudative pleural effusions Source: Annual Congress 2010 - Novel approach in diagnosis and treatment of pleural effusions Year: 2010 Pleural fluid procalcitonin levels in identifying pleural effusions due to infection Source: Annual Congress 2009 - Aetiology and diagnosis of lower respiratory tract infections Year: 2009